期刊文献+

奥拉西坦在颅脑损伤中的应用及疗效 被引量:17

原文传递
导出
摘要 奥拉西坦(Oxiracetam)是作用于中枢网状结构的拟胆碱能益智药,可透过血脑屏障,刺激特异性中枢神经通路而达到治疗效果。在临床上主要用于痴呆、休克、老年性精神衰退综合征、低能儿童的大脑发育以及改善正常人的记忆力。有报道对于急慢性缺血性脑病应用奥拉西坦进行治疗也能获得较好的临床效果。
作者 刘科
出处 《中华神经外科杂志》 CSCD 北大核心 2012年第5期538-540,共3页 Chinese Journal of Neurosurgery
基金 重庆市医疗特色专科基金资助项目(渝卫科教(2010]52)
  • 相关文献

参考文献28

  • 1胡焕顺,刘振宝.奥拉西坦注射液对急性脑梗死患者的疗效观察[J].神经病学与神经康复学杂志,2008,5(1):4-6. 被引量:8
  • 2唐胜南.奥拉西坦治疗脑梗死后遗症的临床观察[J].中国实用神经疾病杂志,2008,11(4):43-44. 被引量:12
  • 3但炜,孙晓川,刘福英,唐文渊.奥拉西坦对急性轻型脑伤患者功能的影响[J].创伤外科杂志,2006,8(3):260-262. 被引量:4
  • 4郁毅刚,汪求精,蔡颖谦,姚谦明,丁涟沭,何旭英.奥拉西坦治疗中、重型脑损伤认知障碍临床研究[J].中华神经外科疾病研究杂志,2005,4(4):368-369. 被引量:6
  • 5Sara S J, Lefevre D. Hypoxia induced amnesia in one trial lear- ning and pharma-cological protection by piracetam. Psychopharmacologia( Berlin), 1972, 25:32-40.
  • 6Hiramatsu N, Shiotani T, Kameyama T, et al. Effects of neff- racetam on amnesia animal models with neuronal dysfunctions. Behav Brain Res, 1997, 83 : 107-115.
  • 7Ammassari-Teule M, D'Amato FR, Sansone M, et al. Enhan- cement of radial maze performances in CD1 mice after prenatal exposure to oxiracetam: possible role of sustained investigative responses developed during ontogeny. Physiol Behav, 1988,42: 281-285.
  • 8Ammassari-Teule M, D'Amato FR, Sansone M, et al. Avoidance fa-cilitation in adult mice by prenatal administration of the nootropic drug oxiracetam. Pharmacol Res Commun, 1986, 12 : 1169-1176.
  • 9Pepeu G, Spignoli G. Nootropic drugs and brain cholinergic me- chanisms. Prog Neuropsychopharmacol Biol Psychiatry, 1989,13 (Suppl) :77-88.
  • 10Spignoli G, Pedata F, Giovannelli L, et al. Effect of oxiraeetam and piracetam on central cholinergic mechanisms and active-avoidance acquisition. Clin Neuropharmacol, 1986,9 ( Suppl 3 ) :39-47.

二级参考文献49

共引文献145

同被引文献108

  • 1简文佳,时晶,倪敬年,魏明清,田金洲.日常生活能力量表鉴别痴呆与轻度认知损害[J].中国老年学杂志,2014,34(4):865-868. 被引量:73
  • 2高燕,赵雪生.创伤性休克治疗指南解读[J].创伤与急危重病医学,2013,1(1):21-24. 被引量:22
  • 3张赛.颅脑创伤后神经行为障碍的认识和药物治疗[J].中华神经外科杂志,2007,23(7):481-482. 被引量:27
  • 4Miiller T. Drug therapies for neuropsychiatric and autonomic disturbancesin patients with PD( J]. Future Med,2012;11 (10) :76-87.
  • 5Kloner RA, Comstock G, Levine LA,ef al. Investigational noncardiovascu-lar uses of phosphodiesterase-5 inhibitors [ J ]. Expert Opin Pharmacother,2011 ;12(15) :2297-313.
  • 6血管性认知功能损害的专家共识[J].中华内科杂志,2007,46(12):1052-1055. 被引量:261
  • 7Mailer T. Drug therapies for neuropsychiatrie andautonomic disturbances in patients with PD [J], FutureMed, 2012, 11(10): 76-87.
  • 8Cloots,R.J.H.,Van Dommelen,J.A.W.,Kleiven,S,et al.Multi-scale mechanics of traumatic brain injury:Predicting axonal strains from head loads[J].Biomechanics and modeling in mechanobiology,2013,12(1):137-150.
  • 9Pandor A,Goodacre S,Haman S,et al.Diagnostic management strategies for adults and children with minor head injury:a systematic review and an economic evaluation[J].Health Technol Assess,2011,15(27):1-202.
  • 10Pearl PL,Mc Carter R,Mc Gavin CL,et al.Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy[J].Epilepsia,2013,54(9):135-137.

引证文献17

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部